Position history for BlackRock, Inc.'s holdings in AVIDITY BIOSCIENCES INC
BlackRock, Inc. holds 12.9M shares of RNA (AVIDITY BIOSCIENCES INC), worth $926.9M as of 2025-Q4. The position was increased (++39.6% shares). RNA represents 0.0% of BlackRock, Inc.'s portfolio.
Current Value
$926.9M
Current Shares
12.9M
Total Value Change
+$638.1M
Total Shares Change
+2.9M
Other major holders of RNA: VANGUARD GROUP INC, FMR LLC, UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC, BNP PARIBAS FINANCIAL MARKETS, JANUS HENDERSON GROUP PLC
Increased |
| 12.9M |
+39.6% |
| $926.9M |
| 0.0% |
| $72.15 |
42 |
| 2025-Q3 | Decreased | 9.2M | -1.4% | $401M | 0.0% | $42.63 | 0 |
| 2025-Q2 | Decreased | 9.3M | -5.8% | $265.2M | 0.0% | $29.03 | 0 |
| 2025-Q1 | Decreased | 9.9M | -0.1% | $292.8M | 0.0% | $31.60 | 0 |
| 2024-Q4 | New | 9.9M | - | $288.8M | 0.0% | $29.18 | 43 |